These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3983039)

  • 61. Adjuvant treatment in high-risk breast cancer.
    Jones A
    Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):156-8. PubMed ID: 8777488
    [No Abstract]   [Full Text] [Related]  

  • 62. A randomized, multicenter prospective trial assessing long-acting release octreotide pamoate plus tamoxifen as a first line therapy for advanced breast carcinoma.
    Bajetta E; Procopio G; Ferrari L; Martinetti A; Zilembo N; Catena L; Alú M; Della TS; Alberti D; Buzzoni R
    Cancer; 2002 Jan; 94(2):299-304. PubMed ID: 11900215
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chemotherapy and endocrine therapy in metastatic disease.
    Pritchard KI
    Curr Opin Oncol; 1989 Dec; 1(2):324-32. PubMed ID: 2489975
    [No Abstract]   [Full Text] [Related]  

  • 64. Adjuvant chemotherapy of breast cancer: a promising experiment or standard practice?
    Henderson IC
    J Clin Oncol; 1985 Feb; 3(2):140-3. PubMed ID: 3881560
    [No Abstract]   [Full Text] [Related]  

  • 65. Randomized trial of tamoxifen alone or combined with aminoglutethimide and hydrocortisone in women with metastatic breast cancer.
    Ingle JN; Green SJ; Ahmann DL; Long HJ; Edmonson JH; Rubin J; Chang MN; Creagan ET
    J Clin Oncol; 1986 Jun; 4(6):958-64. PubMed ID: 3519885
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Whether or not to give adjuvant chemotherapy for breast cancer.
    Smith IE
    Postgrad Med J; 1988 Dec; 64(758):937-40. PubMed ID: 3256809
    [No Abstract]   [Full Text] [Related]  

  • 67. Sequential hormonochemotherapy in advanced breast cancer.
    Hart LL
    Br Med J (Clin Res Ed); 1988 Jan; 296(6617):293-4. PubMed ID: 3124925
    [No Abstract]   [Full Text] [Related]  

  • 68. [Therapeutic results in metastasizing breast carcinoma following hormonal and cytostatic therapy].
    Trams G; Jonat W; Maass H
    Arch Gynakol; 1975 Nov; 219(1-4):159-61. PubMed ID: 1243268
    [No Abstract]   [Full Text] [Related]  

  • 69. New information on drug resistance: implications for the adjuvant treatment of breast cancer.
    Goldie JH
    Recent Results Cancer Res; 1989; 115():8-16. PubMed ID: 2696044
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tamoxifen for breast cancer.
    Legha SS
    Ann Intern Med; 1978 Apr; 88(4):574. PubMed ID: 637442
    [No Abstract]   [Full Text] [Related]  

  • 71. Letter: Prophylactic chemotherapy for breast cancer.
    Marchant J
    Br Med J; 1976 Jun; 1(6025):1589. PubMed ID: 1276779
    [No Abstract]   [Full Text] [Related]  

  • 72. How long?
    Sledge GW
    Clin Breast Cancer; 2003 Oct; 4(4):238. PubMed ID: 14651766
    [No Abstract]   [Full Text] [Related]  

  • 73. Targeted therapies: Using β-blockers to inhibit breast cancer progression.
    Powe DG; Entschladen F
    Nat Rev Clin Oncol; 2011 Aug; 8(9):511-2. PubMed ID: 21808268
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hematopoietic growth factors in breast cancer--overview.
    Osborne CK
    Breast Cancer Res Treat; 1991 Dec; 20 Suppl():S1-2. PubMed ID: 1806028
    [No Abstract]   [Full Text] [Related]  

  • 75. Has the cure of breast cancer with chemotherapy become a reality?
    Greenspan EM
    Cancer Invest; 1994; 12(1):98-100. PubMed ID: 8281469
    [No Abstract]   [Full Text] [Related]  

  • 76. Adjunctive chemotherapy and breast carcinoma.
    Garrett MJ
    Br Med J; 1977 May; 1(6072):1351. PubMed ID: 861622
    [No Abstract]   [Full Text] [Related]  

  • 77. How Effective is the Treatment of Locally Advanced and Metastatic Breast Cancer in Developing Centres?: A Retrospective Review.
    Olayide A; Samuel O; Ganiyu R; Moses A; Gafar O; Abiola D; Dapo K; John A
    Ethiop J Health Sci; 2015 Oct; 25(4):337-44. PubMed ID: 26949298
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Suppression of in vitro peripheral blood lymphocyte mitogenesis by cytotoxic drugs commonly used in the treatment of breast cancer: a comparative study.
    Gereis M; Burford-Mason AP; Watkins SM
    Agents Actions; 1987 Dec; 22(3-4):324-9. PubMed ID: 3445826
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.
    Buckley MM; Goa KL
    Drugs; 1989 Apr; 37(4):451-90. PubMed ID: 2661195
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Controversies in the medical management of breast cancer.
    Smith IE
    Postgrad Med J; 1985 Feb; 61(712):117-22. PubMed ID: 3983039
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.